Better Late Than Never: The FDA's Sodium Reduction Targets
Am J Public Health
.
2022 Feb;112(2):191-193.
doi: 10.2105/AJPH.2021.306627.
Authors
Mhairi K Brown
1
,
Jing Song
1
,
Graham A MacGregor
1
,
Monique Tan
1
,
Feng J He
1
Affiliation
1
All authors are with the Wolfson Institute of Population Health, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom.
PMID:
35080943
PMCID:
PMC8802606
DOI:
10.2105/AJPH.2021.306627
No abstract available
Publication types
Editorial
Comment
MeSH terms
Drug Approval*
Humans
Sodium*
United States
United States Food and Drug Administration
Substances
Sodium